CVRx, Inc. (NASDAQ:CVRX – Get Free Report) saw a large growth in short interest in the month of October. As of October 31st, there was short interest totalling 773,200 shares, a growth of 11.8% from the October 15th total of 691,800 shares. Based on an average trading volume of 81,100 shares, the short-interest ratio is currently 9.5 days. Approximately 6.1% of the shares of the company are sold short.
CVRx Stock Performance
Shares of NASDAQ CVRX traded down $0.50 during trading on Friday, hitting $17.70. 89,272 shares of the company were exchanged, compared to its average volume of 185,554. The firm’s fifty day moving average price is $14.86 and its 200 day moving average price is $15.11. The company has a debt-to-equity ratio of 0.17, a current ratio of 13.99 and a quick ratio of 12.52. CVRx has a 1 year low of $6.57 and a 1 year high of $19.94.
CVRx (NASDAQ:CVRX – Get Free Report) last released its quarterly earnings data on Thursday, October 26th. The company reported ($0.43) EPS for the quarter, topping analysts’ consensus estimates of ($0.57) by $0.14. CVRx had a negative net margin of 121.06% and a negative return on equity of 44.62%. The firm had revenue of $10.51 million for the quarter, compared to the consensus estimate of $9.83 million. As a group, analysts anticipate that CVRx will post -2.1 EPS for the current year.
Institutional Investors Weigh In On CVRx
Wall Street Analysts Forecast Growth
Several research firms recently issued reports on CVRX. Lake Street Capital increased their price target on shares of CVRx from $18.00 to $21.00 in a report on Wednesday, July 26th. Piper Sandler boosted their target price on CVRx from $20.00 to $21.00 in a research report on Wednesday, July 26th.
CVRx, Inc, a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF.
- Five stocks we like better than CVRx
- Insider Trades May Not Tell You What You Think
- 3 large caps with red hot RSIs with upside
- How to Invest in Cybersecurity
- Johnson Controls International: Nothing but upside for investors
- What Are Dividend Achievers? An Introduction
- Unity Software’s resilient rebound post-earnings setback
Receive News & Ratings for CVRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVRx and related companies with MarketBeat.com's FREE daily email newsletter.